Skip Navigation Skip to main content
  • Warning Signs
  • Volunteer
  • Donate
return to American Heart Association Newsroom
  • Heart Attack And Stroke Symptoms
  • Volunteer
  • Donate
Newsroom
    • News Media Embargoed Access
    • Login to Password Protected Newsroom
    • Apply for Embargoed Access
    • Embargo Policy and Guidelines
    • American Heart Association Fact Sheets
    • Boilerplates
    • Copyright Permissions
    • Glossary of Scientific Terms
    • Linking Policy
    • Scientific Statements/Guidelines
    • Scientific Publications: Purposes-Processes
    • Statistics
    • Multimedia Resources
    • Animation/Video
    • Images/Graphics
    • Audio
    • Usage Policy
    • Connect With Us
    • Media Contacts
    • Consumer/Media Connections
  • Twitter
  • Facebook
  • YouTube
  • RSS
  • Email Alerts
  1. Newsroom
  2. Search News Releases
  3. Clot-busting meds may be effective up to 24 hours after initial stroke symptoms
Categories: Scientific Conferences & Meetings, Stroke News & Brain Health
|
Published: February 07, 2025

Clot-busting meds may be effective up to 24 hours after initial stroke symptoms

American Stroke Association International Stroke Conference – Late-Breaking Science Presentation LB 41
facebook Facebook
twitter Twitter
facebook LinkedIn
facebook Email
facebook Print

Related Images

Previous Slide Next Slide

Blood clot in the brain

A blood clot in the brain.

copyright American Heart Association 

Download (95.0 kB)
Blood clot in the brain

Blood clot in the brain

A blood clot in the brain.

copyright American Heart Association 


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (95.0 kB) File Permalink

Brain illustration (profile)

Illustration of the human brain

copyright American Heart Association

Download (105.2 kB)
Brain illustration (profile)

Brain illustration (profile)

Illustration of the human brain

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (105.2 kB) File Permalink

Min Lou M.D., Ph.D.

Min Lou, M.D., Ph.D, Professor, the Second Affiliated Hospital of Zhejiang University’s School of Medicine, China.

copyright  Kaili Fu

Download (363.3 kB)
Min Lou M.D., Ph.D.

Min Lou M.D., Ph.D.

Min Lou, M.D., Ph.D, Professor, the Second Affiliated Hospital of Zhejiang University’s School of Medicine, China.

copyright  Kaili Fu


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (363.3 kB) File Permalink

ISC Logo

copyright American Stroke Association

Download (62.9 kB)
ISC Logo

ISC Logo

copyright American Stroke Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (62.9 kB) File Permalink
  • Blood clot in the brain
  • Brain illustration (profile)
  • Min Lou M.D., Ph.D.
  • ISC Logo

Related Video

Previous Slide Next Slide

Dr. Lou ISC25 LB41 extending treatment benefits

Principal investigator, Min Lou, M.D., Ph.D., a professor at the Second Affiliated Hospital of Zhejiang University’s School of Medicine in China, discusses the HOPE Trial (LB41) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025

Download (123.2 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Lou ISC25 LB41 extending treatment benefits

Principal investigator, Min Lou, M.D., Ph.D., a professor at the Second Affiliated Hospital of Zhejiang University’s School of Medicine in China, discusses the HOPE Trial (LB41) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (123.2 MB) File Permalink

Dr. Lou ISC25 LB41 overview

Principal investigator, Min Lou, M.D., Ph.D., a professor at the Second Affiliated Hospital of Zhejiang University’s School of Medicine in China, discusses the HOPE Trial (LB41) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025

Download (124.1 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Lou ISC25 LB41 overview

Principal investigator, Min Lou, M.D., Ph.D., a professor at the Second Affiliated Hospital of Zhejiang University’s School of Medicine in China, discusses the HOPE Trial (LB41) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (124.1 MB) File Permalink

Dr. Lou ISC25 LB41 imaging patients for treatment

Principal investigator, Min Lou, M.D., Ph.D., a professor at the Second Affiliated Hospital of Zhejiang University’s School of Medicine in China, discusses the HOPE Trial (LB41) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025

Download (132.7 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Lou ISC25 LB41 imaging patients for treatment

Principal investigator, Min Lou, M.D., Ph.D., a professor at the Second Affiliated Hospital of Zhejiang University’s School of Medicine in China, discusses the HOPE Trial (LB41) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (132.7 MB) File Permalink

Dr. Lou ISC25 LB41 what's different about this study

Principal investigator, Min Lou, M.D., Ph.D., a professor at the Second Affiliated Hospital of Zhejiang University’s School of Medicine in China, discusses the HOPE Trial (LB41) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025

Download (132.4 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Lou ISC25 LB41 what's different about this study

Principal investigator, Min Lou, M.D., Ph.D., a professor at the Second Affiliated Hospital of Zhejiang University’s School of Medicine in China, discusses the HOPE Trial (LB41) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (132.4 MB) File Permalink

Dr. Lou ISC25 LB41 adding to research we have

Principal investigator, Min Lou, M.D., Ph.D., a professor at the Second Affiliated Hospital of Zhejiang University’s School of Medicine in China, discusses the HOPE Trial (LB41) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025

Download (75.4 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Lou ISC25 LB41 adding to research we have

Principal investigator, Min Lou, M.D., Ph.D., a professor at the Second Affiliated Hospital of Zhejiang University’s School of Medicine in China, discusses the HOPE Trial (LB41) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt) 

News release

copyright American Heart Association 2025


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (75.4 MB) File Permalink
  • Dr. Lou ISC25 LB41 extending treatment benefits
  • Dr. Lou ISC25 LB41 overview
  • Dr. Lou ISC25 LB41 imaging patients for treatment
  • Dr. Lou ISC25 LB41 what's different about this study
  • Dr. Lou ISC25 LB41 adding to research we have
AHA Logo
This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.
CLOSE PROCEED